130 related articles for article (PubMed ID: 16984506)
21. Long-term treatment of patients with gastro-oesophageal reflux disease in routine care - results from the ProGERD study.
Nocon M; Labenz J; Jaspersen D; Meyer-Sabellek W; Stolte M; Lind T; Malfertheiner P; Willich SN
Aliment Pharmacol Ther; 2007 Mar; 25(6):715-22. PubMed ID: 17311605
[TBL] [Abstract][Full Text] [Related]
22. Persistence and adherence to proton pump inhibitors in daily clinical practice.
Van Soest EM; Siersema PD; Dieleman JP; Sturkenboom MC; Kuipers EJ
Aliment Pharmacol Ther; 2006 Jul; 24(2):377-85. PubMed ID: 16842465
[TBL] [Abstract][Full Text] [Related]
23. Patient-directed strategy to reduce prescribing for patients with dyspepsia in general practice: a randomized trial.
Krol N; Wensing M; Haaijer-Ruskamp F; Muris JW; Numans ME; Schattenberg G; Balen J; Grol R
Aliment Pharmacol Ther; 2004 Apr; 19(8):917-22. PubMed ID: 15080853
[TBL] [Abstract][Full Text] [Related]
24. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.
Zerbib F; Duriez A; Roman S; Capdepont M; Mion F
Gut; 2008 Feb; 57(2):156-60. PubMed ID: 17951358
[TBL] [Abstract][Full Text] [Related]
25. Randomized clinical trial of laparoscopic total (Nissen) versus posterior partial (Toupet) fundoplication for gastro-oesophageal reflux disease based on preoperative oesophageal manometry.
Booth MI; Stratford J; Jones L; Dehn TC
Br J Surg; 2008 Jan; 95(1):57-63. PubMed ID: 18076018
[TBL] [Abstract][Full Text] [Related]
26. Ten-year outcome of laparoscopic and conventional nissen fundoplication: randomized clinical trial.
Broeders JA; Rijnhart-de Jong HG; Draaisma WA; Bredenoord AJ; Smout AJ; Gooszen HG
Ann Surg; 2009 Nov; 250(5):698-706. PubMed ID: 19801931
[TBL] [Abstract][Full Text] [Related]
27. Healthcare seeking in gastro-oesophageal reflux disease: a qualitative study.
Jones R; Ballard K
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):269-75. PubMed ID: 18334869
[TBL] [Abstract][Full Text] [Related]
28. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication.
Mainie I; Tutuian R; Agrawal A; Adams D; Castell DO
Br J Surg; 2006 Dec; 93(12):1483-7. PubMed ID: 17051602
[TBL] [Abstract][Full Text] [Related]
29. Otolaryngologic manifestations of gastro-oesophageal reflux disease in Lagos.
Somefun OA; Wanda CB; Adesanya AA; Thomas MO; Esan OO
Niger Postgrad Med J; 2006 Sep; 13(3):225-9. PubMed ID: 17066111
[TBL] [Abstract][Full Text] [Related]
30. Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study.
Ruszniewski P; Soufflet C; Barthélémy P
Aliment Pharmacol Ther; 2008 Nov; 28(9):1134-9. PubMed ID: 18671778
[TBL] [Abstract][Full Text] [Related]
31. Study protocol for a randomized controlled trial: the feasibility and impact of cardiovascular absolute risk assessment in Australian general practice.
Wan Q; Harris MF; Zwar N; Campbell T; Patel A; Vagholkar S; McKenzie S; Walker C; Denney-Wilson E;
Am Heart J; 2009 Mar; 157(3):436-41. PubMed ID: 19249412
[TBL] [Abstract][Full Text] [Related]
32. Randomized clinical trial of laparoscopic Nissen fundoplication compared with proton-pump inhibitors for treatment of chronic gastro-oesophageal reflux (Br J Surg 2005; 92: 695-699).
Lenglinger J; Eisler M; Riegler M
Br J Surg; 2005 Oct; 92(10):1298. PubMed ID: 16175518
[No Abstract] [Full Text] [Related]
33. The effect of patient self-completion agenda forms on prescribing and adherence in general practice: a randomized controlled trial.
Hamilton W; Russell D; Stabb C; Seamark D; Campion-Smith C; Britten N
Fam Pract; 2007 Feb; 24(1):77-83. PubMed ID: 17142247
[TBL] [Abstract][Full Text] [Related]
34. Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis.
Lundell L; Miettinen P; Myrvold HE; Hatlebakk JG; Wallin L; Malm A; Sutherland I; Walan A;
Br J Surg; 2007 Feb; 94(2):198-203. PubMed ID: 17256807
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis: the efficacy of proton pump inhibitors for laryngeal symptoms attributed to gastro-oesophageal reflux disease.
Gatta L; Vaira D; Sorrenti G; Zucchini S; Sama C; Vakil N
Aliment Pharmacol Ther; 2007 Feb; 25(4):385-92. PubMed ID: 17269993
[TBL] [Abstract][Full Text] [Related]
36. A cost analysis of gastro-oesophageal reflux disease and dyspepsia in Iran.
Rezailashkajani M; Roshandel D; Shafaee S; Zali MR
Dig Liver Dis; 2008 Jun; 40(6):412-7. PubMed ID: 18342588
[TBL] [Abstract][Full Text] [Related]
37. Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer.
Julian-Reynier C; Genève J; Dalenc F; Genre D; Monnier A; Kerbrat P; Largillier R; Serin D; Rios M; Roché H; Jimenez M; Tarpin C; Maraninchi D;
J Clin Oncol; 2007 Jul; 25(21):3038-44. PubMed ID: 17536083
[TBL] [Abstract][Full Text] [Related]
38. What makes individuals with gastroesophageal reflux disease dissatisfied with their treatment?
Bytzer P
Clin Gastroenterol Hepatol; 2009 Aug; 7(8):816-22. PubMed ID: 19286478
[TBL] [Abstract][Full Text] [Related]
39. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
[TBL] [Abstract][Full Text] [Related]
40. Treatment of postnasal drip with proton pump inhibitors: a prospective, randomized, placebo-controlled study.
Pawar S; Lim HJ; Gill M; Smith TL; Merati A; Toohill RJ; Loehrl TA
Am J Rhinol; 2007; 21(6):695-701. PubMed ID: 18201449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
